Kutscher HL, Tamblin M, Kenney P, Reynolds JL, et al. Weekly pulmonary delivery of beta-glucan-chitosan-poly(lactic co-glycolic) acid
(beta-C-P) nanoparticles with daily standard oral therapy achieves control of
Mycobacterium tuberculosis in BALB/c mice. Antimicrob Agents Chemother 2026 Apr 20:e0028126. doi: 10.1128/aac.00281.
PMID: 42003575
|